Shenzhen Neptunus Bioengineering Co., Ltd. (SHE:000078)
China flag China · Delayed Price · Currency is CNY
1.670
0.00 (0.00%)
Jul 29, 2026, 3:12 PM CST

SHE:000078 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
25,23726,66830,31736,41937,83541,054
Revenue Growth
-14.75%-12.04%-16.75%-3.74%-7.84%2.58%
Gross Profit
2,3392,4692,8323,5183,7764,394
Operating Income
294.6254.72176.9618.73764.951,460
Net Income
-572.28-563.06-1,193-1,690-1,02793.3
Earnings Per Share
-0.22-0.21-0.45-0.64-0.390.04
EPS Growth
------

Revenue by Segment

Fiscal YearFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Jan '23 Jan '22
Pharmaceutical Distribution
16,48620,05723,56627,04430,426
Medical Instruments
9,5559,58812,17910,0859,890
Pharmaceutical Manufacturing
429.71445.79473.12503.01416.31
Health Products, Food
141.7123.4992.02127.12193.99
Unallocated Other
55.39102.93108.7776.08127.23
Total
26,66830,31736,41937,83541,054

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
3,5923,0983,6033,8983,7024,162
Total Debt
11,55311,70210,57811,40111,92212,580
Net Cash (Debt)
-7,960-8,604-6,975-7,502-8,220-8,418
Net Cash Growth
------
Net Cash Per Share
-3.03-3.27-2.65-2.85-3.13-3.20

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
83.68104.3939.54-410.19-64.33866.12
Capital Expenditures
-84.83-127.09-84.6-104.07-94.32-129.23
Free Cash Flow
-1.15-22.7-45.06-514.26-158.65736.89
Free Cash Flow Growth
------50.98%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
9.27%9.26%9.34%9.66%9.98%10.70%
Operating Margin
1.17%0.95%0.58%1.70%2.02%3.56%
Pretax Margin
-2.16%-1.87%-3.57%-4.00%-2.25%1.40%
Profit Margin
-2.27%-2.11%-3.94%-4.64%-2.71%0.23%
FCF Margin
-0.01%-0.08%-0.15%-1.41%-0.42%1.80%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
-----104.08
Forward PE
-18.0818.0818.0818.0818.08
P/FCF Ratio
-----13.18
PS Ratio
0.170.340.220.240.240.24